2. PATHOGENS
Basic Information
Accession number
GCA_000146385.1
Release date
2010-08-27
Organism
Staphylococcus aureus subsp. aureus ATCC BAA-39
Species name
Staphylococcus aureus
Assembly level
Scaffold
Assembly name
ASM14638v1
Assembly submitter
Baylor College of Medicine
Assembly Type
haploid
Genome size
2.9 Mb
GC percent
32.5
Contig count
83
Collection date
-
Sample location
-
Host
Homo sapiens
Isolation source
-
Isolate type
-
Strain
ATCC BAA-39
Isolate
-
ARG List
ORF_ID Pass_Bitscore Best_Hit_Bitscore Best_Hit_ARO Best_Identities ARO Model_type SNPs_in_Best_Hit_ARO Other_SNPs Drug class Resistance mechanism AMR gene family Description
GL397103.1_243 # 228141 # 229289 175.0 182.185 vanT gene in vanG cluster 33.88 ARO:3002972 protein homolog model glycopeptide antibiotic antibiotic target alteration glycopeptide resistance gene cluster; vanT Also known as vanTG, is a vanT variant found in the vanG gene cluster.
GL397103.1_251 # 237033 # 239690 1500.0 1790.01 kdpD 98.76 ARO:3004047 protein homolog model aminoglycoside antibiotic antibiotic efflux kdpDE kdpD is a component of the two-component regulatory system, kdpDE. This system is involved in potassium transport and homeostasis, and has been implicated in virulence factor regulation along with kdpE.
GL397103.1_337 # 336216 # 337658 800.0 955.666 Staphylococcus aureus LmrS 100.0 ARO:3004572 protein homolog model macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump MFS transporters are secondary active transporters with single-polypeptide chains containing 400-600 amino acids that transport small solutes across the membrane by using electrochemical gradients. LmrS has 14 transmembrane helices and, when expressed in E. coli, is capable of extruding a variety of antibiotics inclinding linezolid, trimethoprim, florfenicol, chlorampheniocol, erythromycin, streptomycin, kanamycin, and fusidic acid.
GL397103.1_338 # 337980 # 338447 100.0 298.13 sepA 96.13 ARO:3007012 protein homolog model disinfecting agents and antiseptics antibiotic efflux small multidrug resistance (SMR) antibiotic efflux pump sepA is a multidrug efflux pump that confers resistance to disinfecting agents and dyes.
GL397103.1_339 # 338552 # 339895 200.0 870.537 sdrM 100.0 ARO:3007013 protein homolog model fluoroquinolone antibiotic; disinfecting agents and antiseptics antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump sdrM encodes an efflux pump that confers resistance to norfloxacin and ethidium bromide, making this a multidrug resistance gene.
GL397103.1_499 # 488547 # 488966 260.0 288.886 Staphylococcus aureus FosB 100.0 ARO:3004661 protein homolog model phosphonic acid antibiotic antibiotic inactivation fosfomycin thiol transferase The Bacillus subtilis fosB gene encodes a fosfomycin resistance protein.
GL397103.1_613 # 608834 # 610234 525.0 533.872 norC 59.4 ARO:3007010 protein homolog model fluoroquinolone antibiotic; disinfecting agents and antiseptics antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump NorC is a multidrug efflux pump in Staphylococcus aureus that confers resistance to fluoroquinolones and other structurally unrelated antibiotics like tetracycline. It shares 61% similarity with NorB, and is a structural homolog of Blt of Bacillus subtilis. Like NorA and NorB, NorC is regulated by mgrA, also known as NorR.
GL397103.1_756 # 767014 # 767859 500.0 537.339 PC1 beta-lactamase (blaZ) 96.09 ARO:3000621 protein homolog model penam antibiotic inactivation BlaZ beta-lactamase The blaZ beta-lactamase is found in Bacillus subtilis and Staphylococcus aureus.
GL397103.1_956 # 994064 # 995443 850.0 892.108 tet(K) 100.0 ARO:3000178 protein homolog model tetracycline antibiotic antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump TetK is a tetracycline efflux protein found in both Gram-negative (Haemophilus and Gallibacterium) and Gram-positive (many species, including mycobacteria) bacteria.
GL397103.1_964 # 1001457 # 1003463 1250.0 1340.48 mecA 99.7 ARO:3000617 protein homolog model penam antibiotic target replacement methicillin resistant PBP2 A foreign PBP2a acquired by lateral gene transfer that is able to perform peptidoglycan synthesis in the presence of beta-lactams.
GL397103.1_965 # 1003563 # 1005320 1100.0 1202.96 mecR1 100.0 ARO:3000215 protein homolog model penam antibiotic target replacement methicillin resistant PBP2 mecR1 is a transmembrane spanning and signal transducing protein which in response to interaction with beta-lactam antibiotics results in upregulation of the mecA/mecR1/mecI operon.
GL397103.1_1013 # 1049927 # 1051315 525.0 905.59 norC 100.0 ARO:3007010 protein homolog model fluoroquinolone antibiotic; disinfecting agents and antiseptics antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump NorC is a multidrug efflux pump in Staphylococcus aureus that confers resistance to fluoroquinolones and other structurally unrelated antibiotics like tetracycline. It shares 61% similarity with NorB, and is a structural homolog of Blt of Bacillus subtilis. Like NorA and NorB, NorC is regulated by mgrA, also known as NorR.
GL397103.1_1044 # 1088055 # 1089413 850.0 868.611 tet(38) 99.33 ARO:3000565 protein homolog model tetracycline antibiotic antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump Tet38 is a tetracycline efflux pump found in the Gram-positive Staphylococcus aureus. It is regulated by mgrA, which also regulates NorB.
GL397103.1_1238 # 1315354 # 1315773 250.0 285.804 mepR 100.0 ARO:3000746 protein homolog model glycylcycline; tetracycline antibiotic antibiotic efflux multidrug and toxic compound extrusion (MATE) transporter MepR is an upstream repressor of MepA in Staphylococcus aureus. It is part of the mepRAB operon.
GL397103.1_1239 # 1315880 # 1317235 850.0 885.174 mepA 100.0 ARO:3000026 protein homolog model glycylcycline; tetracycline antibiotic antibiotic efflux multidrug and toxic compound extrusion (MATE) transporter MepA is an efflux protein regulated by MepR and part of the MepRAB cluster. Its presence in Staphylococcus aureus led to multidrug resistance, while it has also been shown to decrease tigecycline susceptibility.
GL397103.1_1300 # 1374153 # 1376072 300.0 1275.38 tet(M) 96.56 ARO:3000186 protein homolog model tetracycline antibiotic antibiotic target protection tetracycline-resistant ribosomal protection protein Tet(M) is a ribosomal protection protein that confers tetracycline resistance. It is found on transposable DNA elements and its horizontal transfer between bacterial species has been documented.
GL397103.1_1836 # 1965785 # 1967185 525.0 647.506 norC 70.77 ARO:3007010 protein homolog model fluoroquinolone antibiotic; disinfecting agents and antiseptics antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump NorC is a multidrug efflux pump in Staphylococcus aureus that confers resistance to fluoroquinolones and other structurally unrelated antibiotics like tetracycline. It shares 61% similarity with NorB, and is a structural homolog of Blt of Bacillus subtilis. Like NorA and NorB, NorC is regulated by mgrA, also known as NorR.
GL397103.1_1858 # 2014241 # 2014900 410.0 442.58 arlR 100.0 ARO:3000838 protein homolog model fluoroquinolone antibiotic; disinfecting agents and antiseptics antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump ArlR is a response regulator that binds to the norA promoter to activate expression. ArlR must first be phosphorylated by ArlS.
GL397103.1_1859 # 2014897 # 2016252 880.0 911.753 arlS 100.0 ARO:3000839 protein homolog model fluoroquinolone antibiotic; disinfecting agents and antiseptics antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump ArlS is a protein histidine kinase that phosphorylates ArlR, a promoter for norA expression.
GL397103.1_2513 # 2705462 # 2706628 700.0 763.066 Staphylococcus aureus norA 99.74 ARO:3004667 protein homolog model fluoroquinolone antibiotic antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump NorA gene cloned from Staphylococcus aureus conferred relatively high resistance to hydrophilic quinolones such as norfloxacin, enoxacin, ofloxacin, and ciprofloxacin in S. aureus and Escherichia coli. Had low or no resistance at all to hydrophobic ones such as nalidixic acid, oxolinic acid, and sparfloxacin in S. aureus and Escherichia coli.
GL397103.1_2522 # 2714279 # 2714722 270.0 301.212 mgrA 100.0 ARO:3000815 protein homolog model fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics antibiotic efflux ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump MgrA, also known as NorR, is a regulator for norA, norB, and tet38. It is a positive regulator for norA expression, but is a direct repressor for norB and an indirect repressor of tet38.
GL397106.1_3 # 1394 # 2125 400.0 496.508 ErmA 100.0 ARO:3000347 protein homolog model macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic antibiotic target alteration Erm 23S ribosomal RNA methyltransferase ErmA confers the MLSb phenotype. Similar to ErmC, Expression of ErmA is inducible by erythromycin. The leader peptide causes attenuation of the mRNA and stabilizes the structure preventing further translation. When erythromycin is present, it binds the leader peptide causing a change in conformation allowing for the expression of ErmA.
GL397106.1_4 # 2251 # 3033 450.0 526.939 ANT(9)-Ia 100.0 ARO:3002630 protein homolog model aminoglycoside antibiotic antibiotic inactivation ANT(9) ANT(9)-Ia is an aminoglycoside nucleotidyltransferase encoded by plasmids and transposons in S. aureus, Enterococcus spp., Mammaliicoccus sciuri, and E. faecalis.
GL397107.1_2 # 401 # 1840 900.0 969.148 AAC(6')-Ie-APH(2'')-Ia bifunctional protein 100.0 ARO:3002597 protein homolog model aminoglycoside antibiotic antibiotic inactivation aminoglycoside bifunctional resistance protein AAC(6')-Ie-APH(2'')-Ia is an aminoglycoside acetyltransferase encoded by plasmids and transposons in S. aureus, E. faecalis, E. faecium and Staphylococcus warneri.
GL397103.1_271 # 257855 # 259120 800.0 840.877 Staphylococcus aureus murA with mutation conferring resistance to fosfomycin 99.29 ARO:3003776 protein variant model G257D phosphonic acid antibiotic antibiotic target alteration antibiotic-resistant murA transferase murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations confers fosfomycin resistance.
GL397103.1_1916 # 2079758 # 2082160 1400.0 1623.6 Staphylococcus aureus parC conferring resistance to fluoroquinolones 99.88 ARO:3003312 protein variant model S80F fluoroquinolone antibiotic antibiotic target alteration fluoroquinolone resistant parC Point mutation in Staphylococcus aureus parC resulting in fluoroquinolone resistance.
VF List
Query_id %Identity E-value Related genes VF ID Virulence factor VFcategory VFcategoryID Characteristics Description Strain
GL397103.1_137 88.832 0.0 eap/map VF0016 Eap/Map Adherence VFC0001 Belongs to MSCRAMMs family; unusual property: Eap can bind back to the S. aureus cell wall (eap/map) extracellular adherence protein Eap/Map [Eap/Map (VF0016) - Adherence (VFC0001)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_138 100.0 1.02E-35 hlb VF0002 Beta-hemolysin Exotoxin VFC0235 (hlb) beta-hemolysin [Beta-hemolysin (VF0002) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus COL] Staphylococcus aureus
GL397103.1_140 100.0 5.04E-80 scn VF0425 SCIN Immune modulation VFC0258 Located on the beta-hemolysin (hlb)-converting bacteriophages (scn) complement inhibitor SCIN [SCIN (VF0425) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_142 99.387 4.65E-116 sak VF0021 Staphylokinase Exoenzyme VFC0251 Bacteria plasminogen activator: staphylokinase, strepokinase, act as cofactor molecules that contribute to exosite formation and enhance the substrate presentation to the enzyme; The gene for Staphylokinase is carried by certain prophages (sak) Staphylokinase precursor [Staphylokinase (VF0021) - Exoenzyme (VFC0251)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_143 100.0 0.0 sea VF0020 SE Exotoxin VFC0235 Constitutes a family of eight single-chain polypeptides (26-28kDa, 228-239 amino acid residues) with a typical disulfide loop; divided into two groups based on amino acid sequence homology: the first group consists of SEA,SEE, SED and SEH, and the second group including SEB, SEC, SEG (sea) staphylococcal enterotoxin A precursor [SE (VF0020) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_190 99.635 0.0 hlb VF0002 Beta-hemolysin Exotoxin VFC0235 (hlb) beta-hemolysin [Beta-hemolysin (VF0002) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus COL] Staphylococcus aureus
GL397103.1_201 66.856 0.0 groEL VF0594 GroEL Adherence VFC0001 GroEL of numerous bacteria, such as L. pneumophila, H. pylori, H. ducreyi, M. avium, S. typhimurium, A. actinomycetemcomitans and B. burgdorferi, has been shown to be involved in adhesion or invasion of various target cells or tissues. (groEL) chaperonin GroEL [GroEL (VF0594) - Adherence (VFC0001)] [Clostridium difficile 630] Clostridium difficile
GL397103.1_207 97.727 4.4E-25 hld VF0007 Delta-hemolysin Exotoxin VFC0235 (hld) delta-hemolysin [Delta-hemolysin (VF0007) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_282 60.8 1.13E-174 cap8P VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8P) type 8 capsular polysaccharide synthesis protein Cap8P [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_373 87.469 0.0 hysA VF0013 Hyaluronate lyase Exoenzyme VFC0251 (hysA) hyaluronate lyase precursor [Hyaluronate lyase (VF0013) - Exoenzyme (VFC0251)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_458 61.421 4.46E-92 ureG VF0050 Urease Stress survival VFC0282 (ureG) urease accessory protein (ureG) [Urease (VF0050) - Stress survival (VFC0282)] [Helicobacter pylori 26695] Helicobacter pylori
GL397103.1_587 97.254 0.0 sbi VF0423 Sbi Immune modulation VFC0258 A secreted protein that is also associated with the bacterial envelope, lacks a C-terminal LPXTG sorting signal (sbi) IgG-binding protein SBI [Sbi (VF0423) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_589 100.0 0.0 hlgA VF0011 Gamma-hemolysin Exotoxin VFC0235 Three protein (HlgA, HlgB, HlgC) are virtually identical in sequence to leukocidin component S and F, thus gamma-hemolysin may act similarly to leukocidin; S component: HlgA, HlgC. F component: HlgB (hlgA) gamma-hemolysin chain II precursor [Gamma-hemolysin (VF0011) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_590 99.683 0.0 hlgC VF0011 Gamma-hemolysin Exotoxin VFC0235 Three protein (HlgA, HlgB, HlgC) are virtually identical in sequence to leukocidin component S and F, thus gamma-hemolysin may act similarly to leukocidin; S component: HlgA, HlgC. F component: HlgB (hlgC) gamma-hemolysin component C [Gamma-hemolysin (VF0011) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_591 100.0 0.0 hlgB VF0011 Gamma-hemolysin Exotoxin VFC0235 Three protein (HlgA, HlgB, HlgC) are virtually identical in sequence to leukocidin component S and F, thus gamma-hemolysin may act similarly to leukocidin; S component: HlgA, HlgC. F component: HlgB (hlgB) gamma-hemolysin component B [Gamma-hemolysin (VF0011) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_665 82.911 0.0 fnbB VF0010 FnBPs Adherence VFC0001 Belongs to MSCRAMMs family; most strains of S. aureus express two related Fn-binding proteins FnBPA and FnBPB, which are encoded by closely linked genes (fnbB) fibronectin-binding protein B [FnBPs (VF0010) - Adherence (VFC0001)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_666 85.98 0.0 fnbA VF0010 FnBPs Adherence VFC0001 Belongs to MSCRAMMs family; most strains of S. aureus express two related Fn-binding proteins FnBPA and FnBPB, which are encoded by closely linked genes (fnbA) fibronectin-binding protein A [FnBPs (VF0010) - Adherence (VFC0001)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_822 93.124 0.0 aur VF0024 Aureolysin Exoenzyme VFC0251 The aur gene encoding aureolysin is present in two allelic forms: type I and type II; low substrate specificity: cleaving peptide bonds on the N-terminal side of bulky, aliphatic, hydrophobic residues (aur) zinc metalloproteinase aureolysin [Aureolysin (VF0024) - Exoenzyme (VFC0251)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_851 100.0 2.31E-134 icaR VF0014 Intercellular adhesion proteins Biofilm VFC0271 IcaA, icaB, icaC, icaD synthesize a polysaccharide, poly-n-succinyl-beta-1,6 glucosamine (PNSG) during infection (icaR) ica operon transcriptional regulator IcaR [Intercellular adhesion proteins (VF0014) - Biofilm (VFC0271)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_852 99.757 0.0 icaA VF0014 Intercellular adhesion proteins Biofilm VFC0271 IcaA, icaB, icaC, icaD synthesize a polysaccharide, poly-n-succinyl-beta-1,6 glucosamine (PNSG) during infection (icaA) N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis [Intercellular adhesion proteins (VF0014) - Biofilm (VFC0271)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_853 98.02 1.19E-69 icaD VF0014 Intercellular adhesion proteins Biofilm VFC0271 IcaA, icaB, icaC, icaD synthesize a polysaccharide, poly-n-succinyl-beta-1,6 glucosamine (PNSG) during infection (icaD) intercellular adhesion protein D, involved in polysaccharide intercellular adhesin(PIA) synthesis [Intercellular adhesion proteins (VF0014) - Biofilm (VFC0271)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_854 98.621 0.0 icaB VF0014 Intercellular adhesion proteins Biofilm VFC0271 IcaA, icaB, icaC, icaD synthesize a polysaccharide, poly-n-succinyl-beta-1,6 glucosamine (PNSG) during infection (icaB) N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis [Intercellular adhesion proteins (VF0014) - Biofilm (VFC0271)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_855 98.951 0.0 icaC VF0014 Intercellular adhesion proteins Biofilm VFC0271 IcaA, icaB, icaC, icaD synthesize a polysaccharide, poly-n-succinyl-beta-1,6 glucosamine (PNSG) during infection (icaC) intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis [Intercellular adhesion proteins (VF0014) - Biofilm (VFC0271)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_856 100.0 2.39E-24 icaC VF0014 Intercellular adhesion proteins Biofilm VFC0271 IcaA, icaB, icaC, icaD synthesize a polysaccharide, poly-n-succinyl-beta-1,6 glucosamine (PNSG) during infection (icaC) intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis [Intercellular adhesion proteins (VF0014) - Biofilm (VFC0271)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_857 97.941 0.0 lip VF0012 Lipase Exoenzyme VFC0251 Organized as pre-pro-enzymes: the pre-region represents the signal peptide; secreted in the pro-lipase form. The pro-region protects the proteins from proteolytic degradation and acts as an intramolecular chaperone to facilitate translocation of the lipase (lip) triacylglycerol lipase precursor [Lipase (VF0012) - Exoenzyme (VFC0251)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_878 97.778 0.0 cna VF0005 CNA Adherence VFC0001 Belongs to MSCRAMMs family (cna) collagen adhesin precursor [CNA (VF0005) - Adherence (VFC0001)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_924 96.373 0.0 adsA VF0422 AdsA Immune modulation VFC0258 Harbors two 5'-nucleotidase motifs and a C-terminal LPXTG motif sorting signal (adsA) Adenosine synthase A [AdsA (VF0422) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1018 100.0 2.07E-37 spa VF0017 SpA Exotoxin VFC0235 Belongs to MSCRAMMs family (spa) Immunoglobulin G binding protein A precursor [SpA (VF0017) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1055 64.302 0.0 lap VF0444 Lap Adherence VFC0001 Originally named surface protein p104, is a 104 kDa adhesion protein, present in every Listeria spp. except L. grayi (lap) Listeria adhesion protein Lap [Lap (VF0444) - Adherence (VFC0001)] [Listeria monocytogenes EGD-e] Listeria monocytogenes
GL397103.1_1057 95.614 2.2E-162 cap8B VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8B) type 8 capsular polysaccharide synthesis protein Cap8B [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1058 99.213 0.0 cap8C VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8C) type 8 capsular polysaccharide synthesis protein Cap8C [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1059 96.774 1.29E-32 cap8D VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8D) type 8 capsular polysaccharide synthesis protein Cap8D [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1060 98.78 0.0 cap8D VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8D) type 8 capsular polysaccharide synthesis protein Cap8D [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1061 99.708 0.0 cap8E VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8E) type 8 capsular polysaccharide synthesis protein Cap8E [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1062 99.187 0.0 cap8F VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8F) type 8 capsular polysaccharide synthesis protein Cap8F [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1063 99.198 0.0 cap8G VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8G) type 8 capsular polysaccharide synthesis protein Cap8G [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1064 97.772 0.0 cap8H VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8H) type 8 capsular polysaccharide synthesis protein Cap8H [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1065 98.922 0.0 cap8I VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8I) type 8 capsular polysaccharide synthesis protein Cap8I [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1066 99.459 1.99E-134 cap8J VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8J) type 8 capsular polysaccharide synthesis protein Cap8J [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1067 99.272 0.0 cap8K VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8K) type 8 capsular polysaccharide synthesis protein Cap8K [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1068 99.002 0.0 cap8L VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8L) type 8 capsular polysaccharide synthesis protein Cap8L [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1069 98.919 6.33E-136 cap8M VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8M) type 8 capsular polysaccharide synthesis protein Cap8M [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1070 97.966 0.0 capN VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (capN) capsular polysaccharide type 5/8 biosynthesis epimerase CapN [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1071 99.286 0.0 cap8O VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8O) type 8 capsular polysaccharide synthesis protein Cap8O [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1072 98.425 0.0 cap8P VF0003 Capsule Immune modulation VFC0258 Produced by over 90% of Staphylococcus aureus strains. Two serotypes (5 and 8) predominate among clinical isolates of S. aureus from humans (cap8P) type 8 capsular polysaccharide synthesis protein Cap8P [Capsule (VF0003) - Immune modulation (VFC0258)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1073 99.074 2.81E-78 isdI VF0015 Isd Nutritional/Metabolic factor VFC0272 (isdI) staphylobilin-forming heme oxygenase IsdI [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_1129 71.698 0.0 coa VF0421 Staphylocoagulase Exoenzyme VFC0251 (coa) staphylocoagulase precursor [Staphylocoagulase (VF0421) - Exoenzyme (VFC0251)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1182 100.0 8.66E-67 esxA VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (esxA) type VII secretion system secreted protein EsxA [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1183 99.405 0.0 esaA VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (esaA) type VII secretion system protein EsaA [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1184 99.342 8.35E-110 essA VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (essA) type VII secretion system protein EssA, monotopic membrane protein [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1185 100.0 6.11E-54 esaB VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (esaB) type VII secretion system protein EsaB [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1186 99.324 0.0 essB VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (essB) type VII secretion system protein EssB, monotopic membrane protein [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1187 82.07 0.0 essC VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (essC) type VII secretion system protein EssC, FtsK/SpoIIIE family ATPase [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1196 93.252 4.13E-111 esaG VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (esaG) TIGR01741 family protein [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1197 87.349 1.64E-107 esaG VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (esaG) TIGR01741 family protein [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1198 86.42 1.7E-103 esaG VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (esaG) TIGR01741 family protein [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1203 82.203 2.08E-70 esaG VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (esaG) TIGR01741 family protein [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1204 82.53 6.78E-102 esaG VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (esaG) TIGR01741 family protein [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1205 91.111 1.08E-57 esaG VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (esaG) TIGR01741 family protein [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1206 89.655 8.0E-12 esaG VF0403 Type VII secretion system Effector delivery system VFC0086 At the molecular level, the S. aureus T7SS is composed of four membrane-associated proteins (EsaA, EssA, EssB, and EssC), three soluble cytosolic proteins (EsaB, EsaE, and EsaG), and five secreted virulence factors (EsxA, EsxC, EsxB, EsxD, and EsaD) (esaG) TIGR01741 family protein [Type VII secretion system (VF0403) - Effector delivery system (VFC0086)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1224 97.54 0.0 geh VF0012 Lipase Exoenzyme VFC0251 Organized as pre-pro-enzymes: the pre-region represents the signal peptide; secreted in the pro-lipase form. The pro-region protects the proteins from proteolytic degradation and acts as an intramolecular chaperone to facilitate translocation of the lipase (geh) glycerol ester hydrolase [Lipase (VF0012) - Exoenzyme (VFC0251)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1330 68.584 1.94E-107 set16 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set16) superantigen-like protein SSL1 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1331 97.403 1.24E-164 set17 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set17) superantigen-like protein SSL2 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1332 97.753 0.0 set18 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set18) superantigen-like protein SSL3 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1333 84.545 0.0 set19 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set19) superantigen-like protein SSL4 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1334 97.863 2.52E-170 set20 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set20) superantigen-like protein SSL5 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1335 82.328 4.64E-135 set21 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set21) superantigen-like protein SSL6 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1336 92.208 2.53E-154 set22 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set22) superantigen-like protein SSL7 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1337 97.414 4.58E-165 set23 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set23) superantigen-like protein SSL8 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1338 93.103 2.6E-159 set24 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set24) superantigen-like protein SSL9 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1339 98.678 1.92E-164 set25 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set25) superantigen-like protein SSL10 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1342 63.043 1.22E-93 set26 VF0990 SSLs Exotoxin VFC0235 A family of 14 proteins located on two genomic clusters (set26) superantigen-like protein SSL11 [SSLs (VF0990) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1458 70.874 1.49E-163 hlgA VF0011 Gamma-hemolysin Exotoxin VFC0235 Three protein (HlgA, HlgB, HlgC) are virtually identical in sequence to leukocidin component S and F, thus gamma-hemolysin may act similarly to leukocidin; S component: HlgA, HlgC. F component: HlgB (hlgA) gamma-hemolysin chain II precursor [Gamma-hemolysin (VF0011) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1459 82.769 0.0 lukF-PV VF0018 PVL Exotoxin VFC0235 PVL, together with gamma-hemolysin and other leukocidins such as LukE-LukD, belongs to the family of bicomponent synergohymenotropic toxins; pore-forming toxin rich in beta-sheet structures (lukF-PV) Panton-Valentine leukocidin chain F precursor [PVL (VF0018) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1553 100.0 0.0 harA VF0015 Isd Nutritional/Metabolic factor VFC0272 (harA) haptoglobin-binding heme uptake protein HarA [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_1554 98.684 2.51E-44 harA VF0015 Isd Nutritional/Metabolic factor VFC0272 (harA) haptoglobin-binding heme uptake protein HarA [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_1555 98.305 2.57E-75 harA VF0015 Isd Nutritional/Metabolic factor VFC0272 (harA) haptoglobin-binding heme uptake protein HarA [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_1714 62.376 9.78E-131 sigA/rpoV VF0257 SigA Regulation VFC0301 In M. tuberculosis, 13 sigma factor genes have been annotated in the genome, 9 of which belong to a special subfamily thought to direct extracytoplasmic functions and various other stress responses (temperature, oxidative stress, pH, and infection of macrophages); sigma A also known as RpoV, is the essential principal mycobacterial sigma factors, necessary for most mycobacterial housekeeping gene transcription; It was the first mycobacterial sigma factor to be associated with virulence (sigA/rpoV) RNA polymerase sigma factor SigA [SigA (VF0257) - Regulation (VFC0301)] [Mycobacterium tuberculosis H37Rv] Mycobacterium tuberculosis
GL397103.1_1763 67.097 0.0 gndA VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (gndA) NADP-dependent phosphogluconate dehydrogenase [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
GL397103.1_1793 95.885 0.0 ebp VF0008 EbpS Adherence VFC0001 Belongs to MSCRAMMs family (ebp) cell surface elastin binding protein [EbpS (VF0008) - Adherence (VFC0001)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_1937 68.116 0.0 katA VF0454 KatA Stress survival VFC0282 (katA) catalase [KatA (VF0454) - Stress survival (VFC0282)] [Neisseria meningitidis MC58] Neisseria meningitidis
GL397103.1_2050 72.464 9.19E-29 acpXL VF0367 LPS Immune modulation VFC0258 Brucella possesses a non-classical LPS as compared with the so-called classical LPS from enterobacteria such as Escherichia coli. B. abortus lipid A possesses a diaminoglucose backbone (rather than glucosamine), and acyl groups are longer (C28 rather than C12 and C16) and are only linked to the core by amide bounds (rather than ester and amide bonds).; In contrast to enterobacterial LPSs, Brucella LPS is several-hundred-times less active and toxic than E. coli LPS.; this is an evolutionary adaptation to an intracellular lifestyle, low endotoxic activity is shared by other intracellular pathogens such as Bartonella and Legionella. (acpXL) acyl carrier protein [LPS (VF0367) - Immune modulation (VFC0258)] [Brucella melitensis bv. 1 str. 16M] Brucella melitensis
GL397103.1_2122 99.373 0.0 hly/hla VF0001 Alpha-hemolysin Exotoxin VFC0235 (hly/hla) Alpha-Hemolysin precursor [Alpha-hemolysin (VF0001) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_2146 100.0 4.18E-78 isdG VF0015 Isd Nutritional/Metabolic factor VFC0272 (isdG) iron-regulated surface determinant protein G [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_2147 100.0 0.0 srtB VF0015 Isd Nutritional/Metabolic factor VFC0272 (srtB) NPQTN specific sortase B [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_2148 100.0 0.0 isdF VF0015 Isd Nutritional/Metabolic factor VFC0272 (isdF) iron-regulated surface determinant protein F, ATP-binding-cassette-type transmembrane transporter [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_2149 100.0 0.0 isdE VF0015 Isd Nutritional/Metabolic factor VFC0272 (isdE) iron-regulated surface determinant protein E [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_2150 100.0 0.0 isdD VF0015 Isd Nutritional/Metabolic factor VFC0272 (isdD) iron-regulated surface determinant protein D [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_2151 100.0 1.4E-166 isdC VF0015 Isd Nutritional/Metabolic factor VFC0272 (isdC) iron-regulated surface determinant protein C [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_2152 99.714 0.0 isdA VF0015 Isd Nutritional/Metabolic factor VFC0272 (isdA) iron-regulated surface determinant protein A [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_2153 100.0 0.0 isdB VF0015 Isd Nutritional/Metabolic factor VFC0272 (isdB) iron-regulated surface determinant protein B, haemoglobin receptor [Isd (VF0015) - Nutritional/Metabolic factor (VFC0272)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_2231 97.024 0.0 sspA VF0023 V8 protease Exoenzyme VFC0251 A member of the glutamyl endopeptidase family of enzymes; narrow substrate specificity: cleaving peptide bonds exclusively on the carbonyl side of aspartate and glutamate residues; synthesized as a preproenzyme, the zymogen undergoes proteolytic activation via cleavage by the staphylococcal extracellular metalloprotease; The ssp gene encoding V8 protease is designated as sspA, and is followed by sspB, which encodes a cysteine protease, and sspC, which encodes a protein of unknown function (sspA) serine protease; V8 protease; glutamyl endopeptidase [V8 protease (VF0023) - Exoenzyme (VFC0251)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_2232 98.982 0.0 sspB VF0006 Staphopain Exoenzyme VFC0251 Staphopains A (encoded by scpA) and B (encoded by sspB) are the major secreted cysteine proteases of S. aureus; A novel type of cysteine proteinase inhibitor, referred as staphostatins (ScpC, SspC), has been recently identified. They specifically inhibit cysteine proteinases (staphopains) (sspB) staphopain cysteine proteinase SspB [Staphopain (VF0006) - Exoenzyme (VFC0251)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_2233 100.0 1.84E-78 sspC VF0006 Staphopain Exoenzyme VFC0251 Staphopains A (encoded by scpA) and B (encoded by sspB) are the major secreted cysteine proteases of S. aureus; A novel type of cysteine proteinase inhibitor, referred as staphostatins (ScpC, SspC), has been recently identified. They specifically inhibit cysteine proteinases (staphopains) (sspC) Staphostatin B [Staphopain (VF0006) - Exoenzyme (VFC0251)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_2389 98.347 6.0E-178 selq VF0020 SE Exotoxin VFC0235 Constitutes a family of eight single-chain polypeptides (26-28kDa, 228-239 amino acid residues) with a typical disulfide loop; divided into two groups based on amino acid sequence homology: the first group consists of SEA,SEE, SED and SEH, and the second group including SEB, SEC, SEG (selq) staphylococcal enterotoxin G precursor [SE (VF0020) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_2390 97.095 1.17E-172 selk VF0020 SE Exotoxin VFC0235 Constitutes a family of eight single-chain polypeptides (26-28kDa, 228-239 amino acid residues) with a typical disulfide loop; divided into two groups based on amino acid sequence homology: the first group consists of SEA,SEE, SED and SEH, and the second group including SEB, SEC, SEG (selk) staphylococcal enterotoxin K precursor [SE (VF0020) - Exotoxin (VFC0235)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_2419 100.0 0.0 vWbp VF0420 VWbp Exoenzyme VFC0251 (vWbp) secreted von Willebrand factor-binding protein precursor [VWbp (VF0420) - Exoenzyme (VFC0251)] [Staphylococcus aureus subsp. aureus str. Newman] Staphylococcus aureus
GL397103.1_2420 94.192 0.0 clfA VF0004 Clumping factor Adherence VFC0001 Belongs to MSCRAMMs family; Ser-Asp rich fibrinogen-binding proteins (the proteins having the SD dipeptide repeats have so far been found only in S. aureus and S. epidermidis); The clfA and clfB genes are not allelic variants but are distinct genes. They are not closely linked, in contrast to the fnbA and fnbB genes (clfA) Clumping factor A, fibrinogen-binding protein [Clumping factor (VF0004) - Adherence (VFC0001)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_2439 77.835 4.73E-114 clpP VF0074 ClpP Stress survival VFC0282 21.6 kDa protein belongs to a family of proteases highly conserved in prokaryotes and eukaryotes (clpP) ATP-dependent Clp protease proteolytic subunit [ClpP (VF0074) - Stress survival (VFC0282)] [Listeria monocytogenes EGD-e] Listeria monocytogenes
GL397103.1_2652 97.502 0.0 sdrE VF0019 SDr Adherence VFC0001 (sdrE) Ser-Asp rich fibrinogen-binding bone sialoprotein-binding protein [SDr (VF0019) - Adherence (VFC0001)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_2653 96.162 0.0 sdrD VF0019 SDr Adherence VFC0001 (sdrD) Ser-Asp rich fibrinogen-binding bone sialoprotein-binding protein [SDr (VF0019) - Adherence (VFC0001)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_2654 94.346 0.0 sdrC VF0019 SDr Adherence VFC0001 (sdrC) Ser-Asp rich fibrinogen-binding bone sialoprotein-binding protein [SDr (VF0019) - Adherence (VFC0001)] [Staphylococcus aureus subsp. aureus MW2] Staphylococcus aureus
GL397103.1_2667 74.619 0.0 tufA VF0460 EF-Tu Adherence VFC0001 (tufA) elongation factor Tu [EF-Tu (VF0460) - Adherence (VFC0001)] [Francisella tularensis subsp. tularensis SCHU S4] Francisella tularensis
GL397103.1_2690 70.0 0.0 clpC VF0072 ClpC Stress survival VFC0282 27-kDa stress protein belongs to the Hsp100/Clp family; Regulation of Clp protease expression is mediated by CtsR, the product of the first gene in the ClpC operon (clpC) endopeptidase Clp ATP-binding chain C [ClpC (VF0072) - Stress survival (VFC0282)] [Listeria monocytogenes EGD-e] Listeria monocytogenes